Joseph M. Gibbons

3.5k total citations
12 papers, 616 citations indexed

About

Joseph M. Gibbons is a scholar working on Infectious Diseases, Virology and Pathology and Forensic Medicine. According to data from OpenAlex, Joseph M. Gibbons has authored 12 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Joseph M. Gibbons's work include COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and HIV Research and Treatment (3 papers). Joseph M. Gibbons is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and HIV Research and Treatment (3 papers). Joseph M. Gibbons collaborates with scholars based in United Kingdom, United States and Australia. Joseph M. Gibbons's co-authors include George M. Shaw, Wade P. Parks, Michael S. Saag, Yuexia Li, Elizabeth S. Parks, Beatrice H. Hahn, Fred A. Gill, Phillip D. Markham, Suzanne Gartner and Robert C. Gallo and has published in prestigious journals such as Nature, Science and Nature Communications.

In The Last Decade

Joseph M. Gibbons

12 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph M. Gibbons United Kingdom	8	381	359	157	147	81	12	616
Haili Tang United States	12	447 1.2×	452 1.3×	134 0.9×	271 1.8×	157 1.9×	21	786
Julie Czartoski United States	11	512 1.3×	356 1.0×	150 1.0×	406 2.8×	163 2.0×	15	890
M. Brad Guffey United States	8	424 1.1×	348 1.0×	149 0.9×	110 0.7×	87 1.1×	9	579
William E. Dowling United States	13	250 0.7×	480 1.3×	149 0.9×	96 0.7×	154 1.9×	18	736
Brenda Larkin United States	8	188 0.5×	262 0.7×	199 1.3×	173 1.2×	162 2.0×	9	521
Russ Byrum United States	9	266 0.7×	167 0.5×	183 1.2×	200 1.4×	74 0.9×	11	533
Betty Willems Belgium	17	660 1.7×	494 1.4×	160 1.0×	210 1.4×	103 1.3×	39	776
Filippo Turrini Italy	15	224 0.6×	171 0.5×	232 1.5×	248 1.7×	127 1.6×	24	640
C. Jane Batten Australia	7	211 0.6×	284 0.8×	93 0.6×	249 1.7×	96 1.2×	7	543
D. C. Montefiori United States	6	344 0.9×	225 0.6×	153 1.0×	210 1.4×	89 1.1×	14	508

Countries citing papers authored by Joseph M. Gibbons

Since Specialization

Citations

This map shows the geographic impact of Joseph M. Gibbons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M. Gibbons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M. Gibbons more than expected).

Fields of papers citing papers by Joseph M. Gibbons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M. Gibbons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M. Gibbons. The network helps show where Joseph M. Gibbons may publish in the future.

Co-authorship network of co-authors of Joseph M. Gibbons

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M. Gibbons. A scholar is included among the top collaborators of Joseph M. Gibbons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M. Gibbons. Joseph M. Gibbons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Chambers, Emma S., Giulia Vivaldi, David A. Jolliffe, et al.. (2024). Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination. npj Vaccines. 9(1). 87–87. 6 indexed citations

Altmann, Daniel M., Catherine J. Reynolds, George Joy, et al.. (2023). Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity. Nature Communications. 14(1). 5139–5139. 20 indexed citations

Miyashita, Lisa, Sean Semple, Joseph M. Gibbons, et al.. (2023). Curbside particulate matter and susceptibility to SARS–CoV-2 infection. SHILAP Revista de lepidopterología. 2(4). 100141–100141. 3 indexed citations

Vivaldi, Giulia, David A. Jolliffe, Sian Faustini, et al.. (2022). Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study. The Journal of Infectious Diseases. 226(11). 1903–1908. 9 indexed citations

Kele, Beatrix, Kathryn Harris, Jon M. Bible, et al.. (2022). Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease. Clinical Infectious Diseases. 75(11). 2016–2018. 18 indexed citations

Gibbons, Joseph M., Corinna Pade, Wenhao Li, et al.. (2022). The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19. Frontiers in Immunology. 12. 813300–813300. 7 indexed citations

Jolliffe, David A., Giulia Vivaldi, Emma S. Chambers, et al.. (2022). Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial. Nutrients. 14(18). 3821–3821. 26 indexed citations

Gibbons, Joseph M., Wing-Yiu Jason Lee, Christopher E. Jones, et al.. (2019). HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity. Journal of Virology. 94(4). 12 indexed citations

Saag, Michael S., Beatrice H. Hahn, Joseph M. Gibbons, et al.. (1988). Extensive variation of human immunodeficiency virus type-1 in vivo. Nature. 334(6181). 440–444. 328 indexed citations

10.

Weiss, Stanley H., James J. Goedert, Suzanne Gartner, et al.. (1988). Risk of Human Immunodeficiency Virus (HIV-1) Infection Among Laboratory Workers. Science. 239(4835). 68–71. 145 indexed citations

11.

Senitzer, David, Joseph M. Gibbons, Amira F. Gohara, & Earl H. Freimer. (1985). Infectious antecedent of immunoblastic lymphoma. Progressive immunosuppression in a patient with lymphogranuloma venereum. The American Journal of Medicine. 78(1). 163–167. 3 indexed citations

12.

Lehmann, Paul F., Joseph M. Gibbons, David Senitzer, Bruce S. Ribner, & Earl H. Freimer. (1983). T lymphocyte abnormalities in disseminated histoplasmosis. The American Journal of Medicine. 75(5). 790–794. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact